Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Event-Related Potential (ERP) Components in Clinical Diagnosis

A legfontosabb adatok

Ki végzi
Boston University
Hol
Boston (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
148 fő vett részt
Kezdés
2023. márc. 6.
Befejezés
2025. máj. 1.
A vizsgálat típusa
Megfigyeléses, 4 csoport
A vizsgált kezelések
  • Electroencephalogram (EEG) system
  • Standard Neuropsychological Testing
  • Additional neuropsychological tests
A regiszteradat frissítve
2025. december 16.
Miért állt le
The sponsor stopped funding the study.

Ki vehet részt

Életkor
20 év – 90 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 23 feltétel megnézéseKevesebb

Ki vehet részt

  • For Mild Alzheimer Disease (AD) dementia
  • Meets probable AD dementia National Institute on Aging and Alzheimer's Association (NIA-AA) criteria
  • 50-90 years old
  • Mini-Mental State Examination (MMSE) 20-27
  • Performance on delayed recall and recognition memory worse than 1.5 standard deviation (SD) for age and education
  • Performance on delayed recall and recognition memory worse than 1.5 SD for age \& education in at least one other cognitive domain (e.g., language, executive functioning) based on other tests in our neuropsychological test battery
  • Dr. Turk and Dr. Budson will confirm all mild AD dementia diagnoses; For Mild cognitive impairment (MCI)
  • MCI due to any etiology 50-90 years old
  • MMSE > 23
  • Performance on delayed recall and recognition memory worse than 1.0 SD for age \& education adjusted norms
  • Dr. Turk and Dr. Budson will confirm all MCI diagnoses; For Healthy older adults
  • 50-90 years old
  • Functioning normally in occupation determined by self-report; For Healthy younger adults
  • 20-50 years old
  • Functioning normally in occupation determined by self-report

Ki nem vehet részt

  • heavy alcohol or drug use
  • A clinically significant problem of any of the following conditions:
  • cerebrovascular disease
  • a different degenerative disease (e.g., fronto-temporal dementia, Parkinson's disease)
  • any medical condition whose severity could significantly impair cognition (e.g., organ failure)
  • on any antipsychotic or epilepsy medication
  • depression
  • Unable to understand the consent form

Helyszínek itt: Egyesült Államok

  • BU Alzheimer Disease CenterBoston, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence. This EEG will not be used to treat, cure, mitigate or diagnosis any disease and there will be no safety or efficacy data collected about the machine for any purpose including support of FDA submission.

A teljes eredeti leírásKevesebb

The investigators will compare the ERP data to that of neuropsychological testing in order to determine the degree of correlation between these two measures. Questionnaires on cognition, mood, and fluency will be administered prior to the EEG to establish a baseline. ERP data from the EEG session will be compared with the results of the neuropsychological battery in order to determine whether the implementation of ERPs in the existing workflow of clinicians can aid in diagnostic accuracy, thus altering clinical management.

A vizsgálat 4 csoportja

  • 75 Mild AD

    75 patients diagnosed with Mild Alzheimer's disease.

    Kezelés: Electroencephalogram (EEG) system és Standard Neuropsychological Testing

  • 75 MCI due to any etiology

    75 patients diagnosed with Mild Cognitive Impairment due to any etiology.

    Kezelés: Electroencephalogram (EEG) system és Standard Neuropsychological Testing

  • 25 Healthy Older Adults

    25 Healthy older adults age: 50-90 (control).

    Kezelés: Electroencephalogram (EEG) system és Standard Neuropsychological Testing

  • 25 Healthy Younger Adults

    25 Healthy younger adults age: 20-50 (control).

    Kezelés: Electroencephalogram (EEG) system, Standard Neuropsychological Testing és Additional neuropsychological tests

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
The Clinical Utility of ERPs in the Diagnosis of Cognitive Impairment
A regiszteradat frissítve
2025. december 16.